|Bid||473.51 x 1100|
|Ask||477.10 x 800|
|Day's range||469.70 - 475.41|
|52-week range||344.63 - 607.54|
|Beta (5Y monthly)||0.91|
|PE ratio (TTM)||3.49|
|Earnings date||26 Apr 2023 - 01 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||592.20|
Verano Holdings Corp. (VRNOF) delivered earnings and revenue surprises of 300% and 0.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Key Insights The projected fair value for Bio-Rad Laboratories is US$452 based on 2 Stage Free Cash Flow to Equity...
Select Medical (SEM) aims to address the post-acute care demand in the Central Florida region through the construction of a specialty hospital in Orlando.